Redeye states that last night's capital raise was well needed.
Redeye retains its positive view on Sdiptech following a Q2 report beating our forecasts by 5%, main...
Redeye states that the Q2 report came in somewhat lower than estimates in terms of sales, but that t...
Redeye comments on Stillfront’s Q2-results which came in close to our expectations and while organic...
We expect soft Q2 results on 17 August. While we expect sales to increase by 7% (-17% organic), lif...
Redeye retains its positive view towards Efecte following an H1 report in line with our expectations...
Redeye is encouraged to see Powercell’s strong business momentum.
Q2e EBITDA of ~SEK 140m Sawn goods prices up ~15% in Q2, could weaken in H2 Trading at EV/EBITDA 4x...
NAVPS down 35% q-o-q, reflecting market conditions Strong cash position for future needs Excessive d...
Sales +19% y-o-y, but EBIT only grew 4% y-o-y Minor changes to sales estimates, but -11% on ‘22e EBI...
Guides for ‘22 sales growth of 90-110% Positive estimate revisions on the news New fair value range ...
Svedbergs levererar fortsatt hög tillväxt drivet av förvärv.
Andra kvartalet bjöd som väntat på stark tillväxt till en vikande marginal.
Adj. EBITA SEK 264m (+10% vs. Infront cons. 241m) Expect 4-6% cons.
Sales trend reversal in Q2 SEK 75m share issue, balance sheet issues resolved Estimates unchanged, ...
Q2 report due Friday, 12 August Scale-up of organization to weigh on margins in Q2… …and notable vol...
Q2-rapporten Nettoomsättning för Q2 uppgick till 9,6 mkr (6,2) med ett rörelseresultat för kvartalet...
9% organisk tillväxt trots höga jämförelsetal... Trots svåra jämförelsetal rapporterade Lagercrantz ...
Redeye comments on today’s news of CEO replacement.
Redeyes view on the Q2 report. With a powerful report and above our estimates, we adjust our forecas...
